In last trading session, Cabaletta Bio Inc (NASDAQ:CABA) saw 2.81 million shares changing hands with its beta currently measuring 2.50. Company’s recent per share price level of $12.41 trading at $1.76 or 16.58% at ring of the bell on the day assigns it a market valuation of $580.79M. That closing price of CABA’s stock is at a discount of -112.33% from its 52-week high price of $26.35 and is indicating a premium of 27.32% from its 52-week low price of $9.02. Taking a look at company’s average trading volume volume of 1.15 million if we extend that period to 3-months.

Cabaletta Bio Inc (NASDAQ:CABA) trade information

Upright in the green during last session for gaining 16.58%, in the last five days CABA remained trading in the red while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $12.41 price level, adding 2.21% to its value on the day. Cabaletta Bio Inc’s shares saw a change of -45.33% in year-to-date performance and have moved -4.24% in past 5-day. Cabaletta Bio Inc (NASDAQ:CABA) showed a performance of -24.74% in past 30-days.

Cabaletta Bio Inc (CABA) estimates and forecasts

Statistics highlight that Cabaletta Bio Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -9.81% of value to its shares in past 6 months, showing an annual growth rate of -10.30% while that of industry is 12.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -26.63% during past 5 years.

CABA Dividends

Cabaletta Bio Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.